Evidence map›Paper›PMID 33187397›Full record

ArticleBiointerphases2020

Design, characterization, and intracellular trafficking of biofunctionalized chitosan nanomicelles.

Weiyi Li, Giulia Suarato, Jillian M Cathcart, Paul R Sargunas, Yizhi Meng

Open access · greenAbstract read
In one paragraph

Article in Biointerphases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. [Drug delivery · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Weiyi LiDepartment of Materials Science and Chemical Engineering, Stony Brook University, Stony Brook, New York 11794.
Giulia SuaratoDepartment of Materials Science and Chemical Engineering, Stony Brook University, Stony Brook, New York 11794.
Jillian M CathcartDepartment of Molecular and Cellular Pharmacology, Stony Brook University, Stony Brook, New York 11794.
Paul R SargunasDepartment of Materials Science and Chemical Engineering, Stony Brook University, Stony Brook, New York 11794.
Yizhi MengDepartment of Materials Science and Chemical Engineering, Stony Brook University, Stony Brook, New York 11794.ORCID 0000000158070544
Stony Brook University · US

Funding

Establishing a Long Island Bioscience HubU01HL127522 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI RUBIN, CLINTON T · 2015 to 2017
$3.0M
NHLBI NIH HHS U01 HL127522
6 · The paper itself

Abstract

The hydrophobically modified glycol chitosan (HGC) nanomicelle has received increasing attention as a promising platform for the delivery of chemotherapeutic drugs. To improve the tumor selectivity of HGC, here an avidin and biotin functionalization strategy was applied. The hydrodynamic diameter of the biotin-avidin-functionalized HGC (cy5.5-HGC-B4F) was observed to be 104.7 nm, and the surface charge was +3.1 mV. Confocal and structured illumination microscopy showed that at 0.1 mg/ml, cy5.5-HGC-B4F nanomicelles were distributed throughout the cytoplasm of MDA-MB-231 breast cancer cells after 2 h of exposure without significant cytotoxicity. To better understand the intracellular fate of the nanomicelles, entrapment studies were performed and demonstrated that some cy5.5-HGC-B4F nanomicelles were capable of escaping endocytic vesicles, likely via the proton sponge effect. Quantitative analysis of the movements of endosomes in living cells revealed that the addition of HGC greatly enhanced the motility of endosomal compartments, and the nanomicelles were transported by early and late endosomes from cell periphery to the perinuclear region. Our results validate the importance of using live-cell imaging to quantitatively assess the dynamics and mechanisms underlying the complex endocytic pathways of nanosized drug carriers.

Indexed as

AvidinBiotinCarbocyaninesCell Line, TumorCell SurvivalChitosanDrug CarriersEndocytosisEndosomesHumansMicroscopy, FluorescenceNanoparticlesParticle SizeAvidinBiotinCarbocyaninesChitosanCY5.5 cyanine dyeDrug Carriersglycol-chitosan

Identifiers

PMID33187397
PMCPMC7666618
OpenAlexW3105683412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.